Today more than half of all US citizens -- and people from 44 other countries -- have access to legal medical cannabis. As this market continues to grow and becomes more mainstream, calls for regulation and the need for the cannabis industry to ensure patient and consumer safety will similarly increase.
Recent Media Coverage
Read recent articles about PerkinElmer below. Clicking a headline will take you to the publication’s website for the full article.
Prahlad Singh, president and chief operating officer, shares an update on PerkinElmer's new office facility in Singapore and growing customer base throughout Southeast Asia.
The guidelines, established with support from PerkinElmer, recommend that all countries adopt universal screening of pregnant women for pre-term preeclampsia at 11-13 weeks’ gestation—as part of a basic first-trimester evaluation protocol.
PerkinElmer is supporting the launch of Parent Project Muscular Dystrophy's (PPMD) pilot program to screen newborns in New York state for Duchenne—one of the most common forms of muscular dystrophy.
Researchers are looking for ways to more easily and effectively access, analyze and spotlight scientific data that is growing in volume and complexity and often dispersed across hard-to-access silos.
PerkinElmer will integrate its big data technology and content into Accenture's cloud-based platform, designed to drive wider efforts in drug discovery and research.
PerkinElmer was recognized as a leader in the scientific instrument industry at the 13th China Scientific Instrument Annual Conference.
As part of our mission to innovate for a healthier world, PerkinElmer is providing laboratories with the analytical tools needed to ensure safe, high-quality and compliant cannabis products.
PerkinElmer will relocate its Canadian demonstration lab to Velocity Garage, giving entrepreneurs and scientists access to the company's lab instruments, software and experts.
GenePrism: Actionable Insights is a new physician-ordered test that analyzes all 59 "medically actionable" genes identified by the American College of Medical Genetics and Genomics.
The Environmental Working Group published its annual “Dirty Dozen” list, which ranks fruits and vegetables by most and least contaminated with pesticide residues. Greg Sears, PerkinElmer’s VP and GM of Chromatography, Mass Spectrometry and Food, weighs in on why pesticide analysis is a critical part of today’s food ecosystem.
Gary Harton, a member of the team focused on pre-implantation genetic testing at PerkinElmer, talks about the process for patients who undergo genetic testing for neurodegenerative diseases.
As with many sectors of the food market, the dairy and dairy product industry is evolving. A growing world population, rising standards of living in developing nations and increases in product variety are reshaping the industry.
Emerald Scientific awarded the "Emerald Test" badges to PerkinElmer, affirming our instruments' ability to accurately detect pesticides, heavy metals, residual solvents, terpenes and potency in cannabis.
Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative.
Dr. Linh Hoang, M.D., Ph.D., vice president of Reproductive Health, outlines why early detection of preeclamspia provides a valuable window of opportunity for vigilance and intervention.
In this "Bold Types" feature, CFO Jamey Mock highlights some of the ways PerkinElmer will look to drive future growth.